Advanced search
Publication Cover
Epigenomics Volume 9, 2017 - Issue 6
Submit an article Journal homepage
3,306
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Methylation of SLFN11 is a Marker of Poor Prognosis and Cisplatin Resistance in Colorectal Cancer

Tao He1 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing100853, China;2 Department of Pathology, The Affiliated Hospital of Logistics University of Chinese People’s Armed Police Force, Tianjin300162, ChinaView further author information
,
Meiying Zhang1 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing100853, China;3 Medical College, NanKai University, Tianjin300071, ChinaView further author information
,
Ruipan Zheng1 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing100853, China;3 Medical College, NanKai University, Tianjin300071, ChinaView further author information
,
Shufang Zheng2 Department of Pathology, The Affiliated Hospital of Logistics University of Chinese People’s Armed Police Force, Tianjin300162, ChinaView further author information
,
Enqiang Linghu1 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing100853, ChinaView further author information
,
James G Herman3 Medical College, NanKai University, Tianjin300071, China;4 The Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAView further author information
&
Mingzhou Guo1 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing100853, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 849-862 | Received 01 Feb 2017, Accepted 27 Mar 2017, Published online: 13 Apr 2017

References

  • Ferlay J , SoerjomataramI , DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 . Int. J. Cancer136 ( 5 ), E359 – E386 ( 2015 ).
  • Center MM , JemalA , SmithRA , WardE . Worldwide variations in colorectal cancer . CA Cancer J. Clin.59 ( 6 ), 366 – 378 ( 2009 ).
  • Armaghany T , WilsonJD . ChuQet al. Geneticalterations in colorectal cancer . Gastrointestinal cancer research.5 ( 1 ), 19 – 27 ( 2012 ).
  • Grady WM , CarethersJM . Genomic and epigenetic instability in colorectal cancer pathogenesis . Gastroenterology135 ( 4 ), 1079 – 1099 ( 2008 ).
  • Nyberg KA , MichelsonRJ , CWP , WeinertTA . Toward maintaining the genome: DNA damage and replication checkpoints . Annu. Rev. Genet.36 ( 1 ), 617 ( 2002 ).
  • Jasperson KW , TuohyTM , NeklasonDW , BurtRW . Hereditary and familial colon cancer . Gastroenterology138 ( 6 ), 2044 – 2058 ( 2010 ).
  • Gao D , HermanJG , GuoM . The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer . Oncotarget7 ( 24 ), 37331 – 37346 ( 2016 ).
  • Schwarz DA , KatayamaCD , HedrickSM . Schlafen, a new family of growth regulatory genes that affect thymocyte development . Immunity9 ( 5 ), 657 – 668 ( 1998 ).
  • Bustos O , NaikS , AyersGet al. Evolution of the Schlafen genes, a gene family associated with embryonic lethality, meiotic drive, immune processes and orthopoxvirus virulence . Gene447 ( 1 ), 1 – 11 ( 2009 ).
  • Mavrommatis E , FishEN , PlataniasLC . The Schlafen family of proteins and their regulation by interferons . J. Interferon Cytokine Res.33 ( 4 ), 206 – 210 ( 2013 ).
  • De La Casa-Esperon E . From mammals to viruses: the Schlafen genes in developmental, proliferative and immune processes . Biomol. Concepts2 ( 3 ), 159 – 169 ( 2011 ).
  • The Cancer Genome ATLAS . http://cancergenome.nih.gov .
  • Zoppoli G , RegairazM , LeoEet al. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents . Proc. Natl Acad. Sci. USA109 ( 37 ), 15030 – 15035 ( 2012 ).
  • Nogales V , ReinholdWC , VarmaSet al. Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs . Oncotarget7 ( 3 ), 3084 – 3097 ( 2016 ).
  • Flejou JF . [WHO Classification of digestive tumors: the fourth edition] . Ann. Pathol.31 ( Suppl. 5 ), S27 – S31 ( 2011 ).
  • Morandi L . WO2011104695 A2 ( 2011 ).
  • Samowitz WS , SweeneyC , HerrickJet al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers . Cancer Res.65 ( 14 ), 6063 ( 2005 ).
  • Herman JG , GraffJR , MyöhänenS , NelkinBD , BaylinSB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands . Proc. Natl Acad. Sci. USA93 ( 18 ), 9821 – 9826 ( 1996 ).
  • Ogino S , KawasakiT , KirknerGJ , KraftP , LodaM , FuchsCS . Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample . J. Mol. Diagn.9 ( 3 ), 305 – 314 ( 2007 ).
  • Basile KJ , AbelEV , DadpeyN , HartsoughEJ , FortinaP , AplinAE . In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors . Cancer Res.73 ( 23 ), 7101 – 7110 ( 2013 ).
  • Zhang X , YueP , FletcherS , ZhaoW , GunningPT , TurksonJ . A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes . Biochem. Pharmacol.79 ( 10 ), 1398 ( 2010 ).
  • Tian L , SongS , LiuXet al. Schlafen-11 platinum drugssensitizes colorectal carcinoma cells toirinotecan . Anticancer Drugs25 ( 10 ), 1175 – 1181 ( 2014 ).
  • Bartkova J , HorejsíZ , KoedKet al. DNA irinotecan damage response as a candidate anti-cancer barrier in early human tumorigenesis . Nature434 ( 7035 ), 864 – 870 ( 2005 ).
  • Rottenberg S , JaspersJE , KersbergenAet al. High sensitivity tumorigenesis of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs . Proc. Natl Acad. Sci.105 ( 44 ), 17079 – 17084 ( 2008 ).
  • Zaanan A , Cuilliere-DartiguesP , GuillouxAet al. Impactof p53 expression and microsatellite instability on stage III colon cancerdisease-free survival in patients treated by 5-fluorouracil and leucovorin withor without oxaliplatin . Annals of oncology: official journal of the European Society for Medical Oncology/ESMO21 ( 4 ), 772 – 780 ( 2010 ).
  • Mu Y , LouJ , SrivastavaMet al. SLFN11 inhibits checkpoint maintenance and homologous recombination repair . EMBO Rep.17 ( 1 ), 94 – 109 ( 2016 ).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.